Fatigue News and Research

RSS

Understanding persistent COVID-19 symptoms: study explores early indicators of long COVID

Researchers investigated early biomarkers of post-acute sequelae of SARS-CoV-2 infection in individuals intensively sampled during the acute phase of COVID-19.

20 Jul 2023

Study explores the effectiveness of caffeine consumption for headaches: trigger or remedy?

Caffeine has a dual role in headaches as it can induces or remediate them.

20 Jul 2023

UC Davis MIND Institute receives 24th consecutive year of NIH funding for FXTAS research

It's been 22 years since UC Davis MIND Institute Medical Director Randi Hagerman and her husband, researcher Paul Hagerman, discovered the neurodegenerative condition called FXTAS (fragile X-associated tremor ataxia syndrome).

19 Jul 2023

Early treatment for multiple sclerosis linked to lower disability risk

People who start taking medication soon after the first signs of multiple sclerosis (MS) may have a lower risk of disability later, according to a study published in the July 19, 2023, online issue of Neurology, the medical journal of the American Academy of Neurology.

19 Jul 2023

A comparison of the lived experiences among extended and long-term young adult cancer survivors

Researchers compared the life experiences of young adult (YA) cancer survivors aged 18 to 39.

18 Jul 2023

Unveiling long COVID: new study explores symptoms and strain variations

Researchers investigated the variation in the clinical and demographic characteristics of acute SARS-CoV-2.

17 Jul 2023

Investigating the role of T-cell immunity in long COVID

Researchers investigates the persistence of symptoms and the immune response in patients recovering from COVID-19.

13 Jul 2023

How shift work and other types of unconventional work affects the gut microbiome

Researchers review different studies analyzing the impact of unconventional work on worker’s health and gut microbiota.

13 Jul 2023

Pembrolizumab combination therapies effective for advanced NSCLC, study shows

While pembrolizumab is an approved treatment for patients with stage III non-small cell lung cancer (NSCLC), only some patients respond to this therapy. Treatment failure, researchers say, is often caused by differences in the tumor microenvironment.

12 Jul 2023

Mitochondrial impairment, not inflammation, may be main driver of Gulf War Illness symptoms

Gulf War Illness (GWI) is a chronic multisymptom health condition affecting one-third of all veterans who served in the 1991 Gulf War, most of whom remain afflicted more than 30 years later.

12 Jul 2023

Cetuximab plus radiotherapy effective in treating locally advanced cutaneous squamous cell cancer

A new research paper was published in Oncotarget's Volume 14 on July 7, 2023, entitled, "Effectiveness and toxicity of cetuximab with concurrent RT in locally advanced cutaneous squamous cell skin cancer: a case series."

12 Jul 2023

Self-reported long COVID symptoms not identified in diagnostic tests

Researchers describe chronic symptoms related to physical or mental functioning following SARS-CoV-2 infection.

12 Jul 2023

Novel vaccine against Lyme disease reported to be safe and effective

Researchers determine the safety and immunogenicity of a novel candidate vaccine against Lyme borreliosis.

11 Jul 2023

Fibromyalgia patients may be at increased risk of death

Fibromyalgia, a condition that causes persistent widespread pain and fatigue, may be linked to a heightened risk of death as a result of vulnerability to accidents, infections, and especially suicide, suggests a pooled data analysis of the available evidence, published in the open access journal RMD Open.

10 Jul 2023

Two anti-inflammatory drugs reduce deaths in severe COVID-19 patients

Two anti-inflammatory drugs, abatacept and infliximab, reduced deaths among patients hospitalized with severe COVID-19, according to a national study led by Washington University School of Medicine in St. Louis. William G. Powderly, MD, (right) who led the large clinical trial, discusses patient conditions with Maanasi Samant, MD, in the intensive care unit at Barnes-Jewish Hospital, one of the major trial sites, during the COVID-19 pandemic.

10 Jul 2023

Moderna provides an update on regulatory submissions for RSV vaccine candidate, mRNA-1345

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today provided an update on regulatory submissions for mRNA-1345, a vaccine for the prevention of RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease (ARD) in adults aged 60 years or older.

10 Jul 2023

The vital role of smartphone apps during the COVID-19 pandemic

At the start of the coronavirus disease 2019 (COVID-19) pandemic, analog techniques like nasopharyngeal swab specimens for polymerase chain reaction (PCR) testing were prominent. The widespread use of nonpharmaceutical interventions (NPIs) such as facemasks and social distancing was reminiscent of the influenza outbreak in 1918.

9 Jul 2023

Unique blood protein patterns in long COVID patients could reveal potential drug targets

Recently published in The Journal of Translational Medicine, a team at Lawson Health Research Institute has discovered unique patterns of blood plasma proteins in patients with long COVID that could reveal potential drug targets to improve patient outcomes.

7 Jul 2023

Review: Patient aggression towards receptionists is a serious workplace safety concern

Patient aggression towards receptionists working in general practice is a "serious workplace safety concern," concludes a review of the available published evidence, published in the open access journal Family Medicine and Community Health.

6 Jul 2023

Women with post-acute sequelae of COVID-19 could be at greater risk of developing hypertension

Post-acute sequelae of COVID-19 (PASC), colloquially referred to as long COVID-19 or long COVID, is when someone recovers from acute COVID-19 but shows a cluster of symptoms for months afterward.

4 Jul 2023

Fatigue News and Research

Understanding persistent COVID-19 symptoms: study explores early indicators of long COVID

Study explores the effectiveness of caffeine consumption for headaches: trigger or remedy?

UC Davis MIND Institute receives 24th consecutive year of NIH funding for FXTAS research

Early treatment for multiple sclerosis linked to lower disability risk

A comparison of the lived experiences among extended and long-term young adult cancer survivors

Unveiling long COVID: new study explores symptoms and strain variations

Investigating the role of T-cell immunity in long COVID

How shift work and other types of unconventional work affects the gut microbiome

Pembrolizumab combination therapies effective for advanced NSCLC, study shows

Mitochondrial impairment, not inflammation, may be main driver of Gulf War Illness symptoms

Cetuximab plus radiotherapy effective in treating locally advanced cutaneous squamous cell cancer

Self-reported long COVID symptoms not identified in diagnostic tests

Novel vaccine against Lyme disease reported to be safe and effective

Fibromyalgia patients may be at increased risk of death

Two anti-inflammatory drugs reduce deaths in severe COVID-19 patients

Moderna provides an update on regulatory submissions for RSV vaccine candidate, mRNA-1345

The vital role of smartphone apps during the COVID-19 pandemic

Unique blood protein patterns in long COVID patients could reveal potential drug targets

Review: Patient aggression towards receptionists is a serious workplace safety concern

Women with post-acute sequelae of COVID-19 could be at greater risk of developing hypertension

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News